Xarelto Blood Thinner Lawsuit: A Comprehensive Characterization

  https://www.medlegal360.com/xarelto-blood-thinner-lawsuit/ The US Food and Drug Administration (FDA) has approved the anticoagulant or blood thinner Xarelto (generic name rivaroxaban) to treat deep vein thrombosis and pulmonary embolism as well as lower the risk of stroke and blood clots in patients with nonvalvular atrial fibrillation (irregular heartbeat) or those who have recently undergone knee or hip replacement surgery. Janssen Pharmaceuticals, Inc manufactured Xarelto. This large pharmaceutical company also produces several well-known medications, including  Elmiron ,  Invokana , Risperdal, and Stelara. The side effects of Xarelto can vary greatly. These detrimental outcomes might only persist for a few days or weeks. If the adverse effects persist, annoy you, or become severe, talk to your doctor or physician. Serious or fatal bleeding, clots after stopping Xarelto, and serious or fatal bleeding are some of the serious Xarelto side effects. Blood clot in the lumbar or e